Mechanistic studies on the phosphorylation of photoexcited rhodopsin  by Fowles, Charles et al.
Volume 238, number 1, 56-60 FEB 06323 September 1988 
Mechanistic studies on the phosphorylation of photoexcited 
rhodopsin 
Charles Fowles, Ram Sharma and M. Akhtar 
Department of Biochemistry, University of Southampton, Bassett Crescent East, Southampton SO9 3TU, England 
Received 3August 1988 
The mechanism of the photophosphorylation of rhodopsin was studied using several synthetic peptides corresponding 
to the sequence of the phosphorylation domain. It was found that the dccapeptide (residues 339-348) was effectively 
phosphorylated by rhodopsin kinase only when incubation was performed in the presence of both rhodopsin and light. 
These results are interpreted to suggest that in the dark-adapted state rhodopsin kinase exists in an inactive conformation 
and that this is converted into a catalytically competent form only after interaction with metarhodopsin II (Rho*) 
Rhodopsin; Rod outer segment; Rhodopsin kinase; Synthetic peptide; Peptide phosphorylation; (Retina) 
1. INTRODUCTION 
Photoactivation of rhodopsin leads to the for- 
mation of bathorhodopsin as the earliest detec- 
table intermediate, the latter then decaying to a 
longer lived species referred to as metarhodopsin 
II. There is much circumstantial evidence to sug- 
gest that the latter species (designated Rho*) is in- 
volved in signal transmission via interaction with 
transducin (fig. 1) [l-4]. Rho* also acts as a 
substrate for rhodopsin kinase [5,6] and this pro- 
cess culminates in the phosphorylation of several 
amino acid residues located in the C-terminal 
region of rhodopsin [7-91. The resultant 
phosphoprotein is proposed to bind to a 48 kDa 
protein (arrestin) forming a complex no longer 
able to interact with transducin, resulting in signal 
termination (fig.1) [lo-121. The mechanism of the 
photophosphorylation has now been studied using 
several synthetic peptides corresponding to the se- 
quence of the phosphorylation domain. 
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2. EXPERIMENTAL 
2.1. Materials 
Labscint scintillation cocktail was obtained from Lablogica 
(Sheffield, England); [y-“P]ATP and NCS tissue solubiliser 
from Amersham; leupeptin, pepstatin A, antipain and soybean 
trypsin inhibitor from Sigma (Poole) and all other chemicals 
from BDH (Poole), Sigma or Interchem. 
2.2. Isolation of rhodopsin kinase and kinase-free rod outer 
segments 
All operations were performed under dim-red safety-light il- 
lumination (25 W bulb with Kodak GBX-2 safelight filter) at 
4°C. Freshly isolated bovine retinae were gently shaken in solu- 
tion A (100 mM Tris-HCI, pH 7.5, 2 mM MgCIz, 0.1 mM 
EDTA, 0.1% ,&mercaptoethanol) containing 45% (w/v) 
sucrose and then carried through to the sucrose density step as 
described [13,14]. The rod outer segments were removed, 
pelleted and washed with solution B (solution A with 1 pg/ml 
each of antipain, leupeptin, pepstatin and soybean trypsin in- 
hibitor added). The pellet was now suspended in solution C 
(distilled water containing 1 pg/ml each of antipain, leupeptin, 
pepstatin and soybean trypsin inhibitor) at 1.2 x 10-s M 
rhodopsin (calculated from Es00 40000 mol. 1-l .cm-‘) and ex- 
tracted by homogenisation to furnish after centrifugation a 
supernatant that was made up to 2 mM MgCI2 and is termed 
kinase extract. 
The membrane pellet from the above was washed with solu- 
tion C and then with 5 M urea. The membrane pellet was finally 
washed and stored in solution B at 1.2 x 10m5 M rhodopsin and 
this sample was found to be free of kinase and used as a source 
of rhodopsin in all experiments described below. 
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Fig.1. The involvement of photoactivated rhodopsin (Rho* = metarhodopsin II) in signal transmission and signal termination 
processes. 
2.3. Assay for kinase activity 
Rhodopsin kinase activity was measured in solution B in a 
final volume of 100 ~1 containing kinase extract (24 pg protein), 
2.34 x lo-’ M rhodopsin and 3 mM [y-“PJATP. Incubation 
was performed at 30°C and the incorporation of szP into the 
protein determined as in 1151. The kinase extract had a specific 
activity of 15 nmol phosphate transferred/min per mg protein 
present in the original extract. 
2.4. Separation and analysis of phosphopeptide 
Samples of the incubation mixtures (5-10 ~1) were centri- 
fuged and the supernatant applied to a cellulose TLC plate 
(Merck 5716, 20 x 20 cm cellulose TLC plates) in 1 cm strips. 
The plate was then subjected to electrophoresis in 
pyridine : acetic acid : water (1 : 10: 89) buffer (pH 3.5) for 2 h at 
7°C and after drying in air was exposed to Fuji NIF RX X-ray 
film for 10 h. Thereafter the film was developed to view 
radioactive bands corresponding to the phosphopeptide. These 
areas of cellulose were then scraped off the plate and analysed 
by scintillation counting in Labscint using a Philips PW470 li- 
quid scintillation counter programmed for automatic quench 
correction. 
3. RESULTS 
Four peptides containing residues 3 18-348, 
329-348, 329-339 and 339-348 (peptides I-IV, 
respectively) of bovine rhodopsin [16] were 
prepared by the Merrifield solid-phase synthesis 
method [ 171. Initially, these peptides were screened 
for their ability to inhibit the light-dependent 
phosphorylation of rhodopsin. It was found that 
although all four peptides inhibited the 
phosphorylation reaction, the decapeptide IV was 
by far the most effective. These results are 
qualitatively similar to those reported for similar 
(but not identical) peptides by Palczewski et al. 
[181. 
A number of experiments were designed in 
which the peptides (I-IV) were incubated with 
[Y-~~P]ATP, rhodopsin kinase and rod outer 
segments in the presence of light and in complete 
darkness. Since the most significant results were 
obtained with the decapeptide IV, experiments per- 
taining to this peptide are considered in detail. 
HzN-Lys-Thr-Glu-Thr-Ser-Gln-Val-Ala-Pro-Ala-COOH 
339 348 
(Peptide IV) 
Fig.2 shows the analysis of various incubation 
mixtures performed under different conditions. In 
Fig.2. Phosphorylation of the synthetic peptide IV under 
various conditions. Incubations were performed for 1 hat 30°C 
under white light illumination (except lane 7) in volumes of 
100~1 solution B (section 2.2). Final concentrations were: 
rhodopsin as indicated, 24 pg rhodopsin kinase, 1 mM peptide 
IV (unless stated) and 3 mM [Y-~~P]ATP (16400 cpm/nmol 
ATP). After incubation the suspensions were centrifuged and 
5-J samples of the supernatant analysed by cellulose TLC 
electrophoresis as in section 2.4. Rhodopsin concentrations 
were: (lanes) 1, 8 x 10m7 M; 2, 2.4 x lOm6 M; 3, 3.6 x 10m6 M; 
4, 1.2 x 10-s M; 5, 2.4 x 10e5 M; 6, no rhodopsin; 7, complete 
system as in lane 5 but incubated in darkness; 8, as in lane 5 but 
without the peptide. 
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the experiments in which incubation was perform- 
ed either in the absence of rhodopsin (lane 6), or 
with rhodopsin but in complete darkness (lane 7), 
or in the absence of peptide (lane 8), no significant 
radioactivity was observed in a region corre- 
sponding to a putative phosphopeptide. However, 
in the experiments containing all components (pep- 
tide, [Y-~~P]ATP, kinase and rod outer segments) 
performed in continuous white light, there was an 
impressive amount of radioactivity associated with 
a band that migrated 10 cm from the origin 
towards the cathode. The intensity of the band 
depended on the amount of rhodopsin (lanes 1-5) 
and optimal phosphorylation of the decapeptide 
was obtained when the rhodopsin concentration 
was 1.2 x 10e5 M. The phosphorylation of a pep- 
tide (residues 337-348 of rhodopsin) by the kinase 
without rhodopsin has been reported when incuba- 
tion was performed for several hours [18]. 
From the aforementioned experiment it appears 
that an effective phosphorylation of the ex- 
ogenously added peptide was intimately linked to 
the photoexcitation of rhodopsin. This aspect was 
further studied by performing experiments in 
which the phosphorylation of rhodopsin and the 
decapeptide was monitored simultaneously under 
different conditions. Fig.3 shows the time course 
of phosphorylation of rhodopsin and the decapep- 
tide and emphasises that both these processes were 
dependent on photoactivation. No significant 
phosphorylation was observed when all com- 
ponents of the reaction mixture were present but 
t 
Time (minutes) 
Fig.3. Time course for the phosphorylation of rhodopsin and the synthetic peptide IV. Phosphorylation of (A) rhodopsin in light; 
(0) rhodopsin in darkness; (m) peptide IV in light; (*) peptide IV (complete system) in darkness or in the absence of rhodopsin. 
Incubations were performed at 30°C in volumes of 100 pl in the presence of white light or in complete darkness as indicated. Final 
concentrations were 2.4 x 10-s M rhodopsin, 60 pg rhodopsin kinase, 1 mM peptide IV and 3 mM [y-“P]ATP (80000 cpm/nmol 32P) 
in solution B (section 2.2). At various time’ intervals, aliquots of the incubation mixtures were centrifuged and the pellet processed 
for the determination of protein-bound radioactivity (section 2.3) and the supernatant subjected to cellulose TLC electrophoresis as 
in section 2.4. For all curves the radioactivity incorporated is shown as that calculated for the total incubation mixture (lOO&. 
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incubation was performed in the dark. The com- 
parison of curve (m) with (*) (fig.3) provides the 
most dramatic illustration of the requirement of 
light as well as rod outer segments for the 
phosphorylation of the peptide. The phosphoryla- 
tion of rhodopsin was maximum at 30 min when 
6.5 nmol phosphate groups were incorporated into 
protein whereas the incorporation into the peptide 
was 0.3 nmol phosphate at this time. 
The remarkable fact that dark-adapted rhodop- 
sin is resistant to the action of the kinase, but 
becomes an effective substrate following photoex- 
citation, may be rationalised by at least two alter- 
native hypotheses. First, the ‘site-accessibility’ 
hypothesis assumes that the C-terminal of rhodop- 
sin, which is the site for the action of the kinase 
[7-91, is inaccessible to the enzyme when rhodop- 
sin is in the dark-adapted state and it is only after 
photoexcitation that a new conformation of the 
visual protein is obtained in which the C-terminal 
region becomes available for modification by the 
kinase (pathway A, fig.4). The second possibility is 
that in the dark state the kinase exists in an inactive 
form and is activated after binding to photoexcited 
rhodopsin (pathway B, fig.4). The domain in 
rhodopsin responsible for the activation may either 
be the C-terminal region and/or another part of 
the rhodopsin molecule that undergoes profound 
conformational change following photoexcitation. 
We have found that of the four peptides used by 
us, the decapeptide IV was the best substrate for 
the kinase and that the phosphorylation of the pep- 
tide was greatly enhanced (1%30-fold) by the 
presence of light as well as rhodopsin. We believe 
that the simplest explanation of these results is that 
photoexcitation leads to the exposure of a region 
of rhodopsin that interacts with the kinase, conver- 
ting the latter into an active form that participates 
in the phosphorylation of the C-terminal and that 
the peptide manages to ‘smuggle’ into the 
Rho*-kinase complex acting as a ‘surrogate’ 
substrate. 
Rhodopsin Rho* active 
Rhodopsin Rho* inactive 
I 
0 (Peptide) 
ATP 
- Phosphopeptide 
CO,H 
Fig.4. Two hypotheses regarding the light activation of rhodopsin phosphorylation. In (A) light excitation exposes the C-terminal of 
rhodopsin to the kinase, while in (B) kinase exists in an inactive form and is rendered catalytically competent only after binding to 
a domain in Rho*. In both the alternatives the major conformational change is shown to occur only in one of the cytoplasmic loops. 
This choice is completely arbitrary and is made for convenience. Peptide refers to peptide IV, comprising residues 339-348 of 
rhodopsin. 
59 
Volume 238, number 1 FEBS LETTERS September 1988 
The model proposed in fig.4 is broadly consis- 
tent with the earlier findings of Kuhn [l] who has 
convincingly shown that rhodopsin kinase binds 
more tightly to Rho* than to native rhodopsin. 
However, it had hitherto been assumed, albeit 
tacitly, that the kinase acts on Rho* only because 
the conformation of the latter species contains the 
phosphorylation sites suitably exposed to the en- 
zyme. Though this still remains a distinct possibili- 
ty, the present work has unravelled a new facet of 
the phosphorylation system showing that the 
kinase only becomes catalytically active after in- 
teracting with Rho*. In the illustration of fig.4, a 
ternary complex (consisting of Rho*, activated 
kinase and peptide) has been invoked to participate 
in reaction with ATP to produce the phosphopep- 
tide. A closely related possibility in which, follow- 
ing interaction with Rho*, the activated ,form of 
the kinase dissociates prior to participating in the 
phosphorylation of the synthetic peptide has not 
yet been eliminated. 
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